Results 1 to 10 of about 1,478,450 (299)

Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects

Frontiers in Cellular and Infection Microbiology, 2021
The appearance and magnitude of the immune response and the related factors correlated with SARS-CoV-2 vaccination need to be defined. Here, we enrolled a prospective cohort of 52 participants who received two doses of inactivated vaccines (BBIBP-CorV ...
Jiaqi Zhang, Jiaqi Zhang, Shan Xing, Dan Liang, Wei Hu, Changwen Ke, Jinyong He, Runyu Yuan, Yile Huang, Yizhe Li, Dongdong Liu, Xuedong Zhang, Lin Li, Jianhua Lin, Weili Li, Xiangyun Teng, Yijun Liu, Wei Wen, Qiang Kang, Dawei Wang, Wanli Liu, Jianhua Xu   +21 more
doaj   +1 more source

Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens? [PDF]

Iranian Journal of Immunology, 2021
Background: Incidence and severity of SARS-CoV2 infection are significantly lower in children and teenagers proposing that certain vaccines, routinely administered to neonates and children may provide cross-protection against this emerging infection ...
Danesh Hassani, Mohammad Mehdi Amiri, Faezeh Maghsood, Vahid Salimi, Gholam Ali Kardar, Omid Barati, Seyed Mohammad Reza Hashemian, Mahmood Jeddi-Tehrani, Amir-Hassan Zarnani, Fazel Shokri   +9 more
doaj   +1 more source

Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort

Frontiers in Immunology, 2021
BackgroundDialysis patients are at high risk for a severe clinical course after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Georg Beilhack, Rossella Monteforte, Florian Frommlet, Martina Gaggl, Robert Strassl, Andreas Vychytil   +5 more
doaj   +1 more source

Prevalence of COVID-19 Virus Infection in Semnan province [PDF]

Iranian Journal of Immunology, 2021
Background: Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) causing a human pandemic disease named COVID-19 has become a major global health concern.
Elahe Jandaghi, Maral Hemati, Maryam Mohammadlou, Jafar Jandaghi, Majid Mirmohammadkhani, Navid Danaei, Parviz Kokhaei   +6 more
doaj   +1 more source

Potent and Persistent Antibody Response in COVID-19 Recovered Patients

Frontiers in Immunology, 2021
SARS-CoV-2 has caused a global pandemic with millions infected and numerous fatalities. Virus-specific antibodies can be detected in infected patients approximately two weeks after symptom onset.
Xiaodong Tian, Xiaodong Tian, Ling Liu, Ling Liu, Wenguo Jiang, He Zhang, Wenjun Liu, Wenjun Liu, Wenjun Liu, Wenjun Liu, Wenjun Liu, Jing Li, Jing Li   +12 more
doaj   +1 more source

Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up

Frontiers in Public Health, 2021
As of November 17, 2021, SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus 2), the causative agent of COVID-19 (COronaVIrus Disease 19), has infected ~250 million people worldwide, causing around five million deaths.
Annachiara Coppola, Annachiara Coppola, Carlo Buonerba, Davide Cardinale, Gabriella Lo Conte, Donato Sansone, Giuseppe Rofrano, Sabato De Vita, Maria Morgante, Maria Triassi, Luigi Atripaldi, Gianfranco Brambilla, Rocco Sabatino, Rocco Sabatino, Andrea Pierri, Daniela Pacella, Antonio Pizzolante, Biancamaria Pierri, Veronica Ferrucci, Massimo Zollo, Mario Capasso, Silvia Stringhini, Paolo Antonio Ascierto, Sante Roperto, Pellegrino Cerino   +24 more
doaj   +1 more source

The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients

Frontiers in Immunology, 2021
Increasing evidence suggests that dysregulated immune responses are associated with the clinical outcome of coronavirus disease 2019 (COVID-19). Nucleocapsid protein (NP)-, spike (S)-, receptor binding domain (RBD)- specific immunoglobulin (Ig) isotypes,
Huanle Luo, Huanle Luo, Tingting Jia, Jiamin Chen, Shike Zeng, Zengzhao Qiu, Shu Wu, Xu Li, Yuxuan Lei, Xin Wang, Weihua Wu, Renli Zhang, Xuan Zou, Tiejian Feng, Ruxia Ding, Yue Zhang, Yao-Qing Chen, Yao-Qing Chen, Caijun Sun, Caijun Sun, Tian Wang, Tian Wang, Tian Wang, Shisong Fang, Yuelong Shu, Yuelong Shu   +25 more
doaj   +1 more source

Immunization against a Conserved Surface Polysaccharide Stimulates Bovine Antibodies with Opsonic Killing Activity but Does Not Protect against Babesia bovis Challenge

Pathogens, 2021
Arthropod-borne apicomplexan pathogens remain a great concern and challenge for disease control in animals and humans. In order to prevent Babesia infection, the discovery of antigens that elicit protective immunity is essential to establish approaches ...
Naomi S. Taus, Colette Cywes-Bentley, Wendell C. Johnson, Gerald B. Pier, Lindsay M. Fry, Michelle R. Mousel, Massaro W. Ueti   +6 more
doaj   +1 more source

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers

Vaccines, 2021
Data about the long-term duration of antibodies after SARS-CoV-2 vaccination are still scarce and are important to design vaccination strategies. In this study, 231 healthcare professionals received the two-dose regimen of BNT162b2.
Jean-Louis Bayart, Jonathan Douxfils, Constant Gillot, Clara David, François Mullier, Marc Elsen, Christine Eucher, Sandrine Van Eeckhoudt, Tatiana Roy, Vincent Gerin, Grégoire Wieers, Christine Laurent, Mélanie Closset, Jean-Michel Dogné, Julien Favresse   +14 more
doaj   +1 more source

Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis

Vaccines, 2021
Patients with rheumatoid arthritis (RA) are treated with drugs that may impact their immune responses to SARS-CoV-2 vaccines. We describe here the anti-Spike (anti-S) IgG and neutralizing antibody responses induced by the mRNA-1273 SARS-CoV-2 vaccine in ...
Yves Michiels, Nadhira Houhou-Fidouh, Gilles Collin, Jérôme Berger, Evelyne Kohli   +4 more
doaj   +1 more source